Andrija Lebar

Title: Andrija Lebar: Innovator in Pharmaceutical Chemistry

Introduction

Andrija Lebar is a notable inventor based in Ljubljana, Slovenia. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel hydrates of dolutegravir sodium. His work has implications for the treatment of retroviral infections, including HIV-1.

Latest Patents

Andrija Lebar holds 1 patent for his invention titled "Hydrates of dolutegravir sodium." This invention relates to novel hydrates of dolutegravir sodium and processes for their preparation. It also introduces a new crystalline form of dolutegravir sodium, which serves as a useful intermediate for creating one of the novel hydrates. Furthermore, the invention discusses the use of these hydrates in producing pharmaceutical compositions, including oral dosage forms for treating retroviral infections.

Career Highlights

Throughout his career, Andrija has worked with various companies, including Lek Pharmaceuticals D.d. His expertise in pharmaceutical chemistry has allowed him to contribute to significant advancements in drug formulation and development.

Collaborations

Andrija has collaborated with notable professionals in his field, including Andreas Hotter and Andrea Thaler. These collaborations have further enriched his research and development efforts.

Conclusion

Andrija Lebar's innovative work in pharmaceutical chemistry, particularly with dolutegravir sodium, showcases his commitment to advancing medical treatments. His contributions are vital in the ongoing fight against retroviral infections.